Haleon, GB00BMX86B70

Haleon stock last trades at GBp 340.20 on September 28, 2026, down 0.73 percent

Published on 09/28/2026 at 21:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Haleon stock last traded at GBp 340.20 on September 28, 2026, down 0.73 percent. Recent company developments include expanded U.S. retail initiatives and products aimed at consumers using GLP-1 drugs.

Arbeiter prüfen unbeschriftete Zahnpasta- und Tablettenpackungen an Produktionslinie
Haleon plc (ISIN GB00BMX86B70) betreibt moderne Produktionsanlagen für rezeptfreie Gesundheitsprodukte und Zahnpflegeartikel weltweit, Illustration mit AI erstellt.

Haleon plc shares listed in London last traded at GBp 340.20 on September 28, 2026, down 0.73 percent from the previous session. The quote was recorded at 3:35:10 p.m. UTC under the ticker HLN.L.

Trading session

The London-listed ordinary shares ended the session at the quoted level. The move is presented separately from Haleon’s previously reported business developments.

Recent company developments

In a September 3 report, Reuters said Haleon had negotiated improved shelf positions at U.S. retailers including Walmart and Target. The company told Reuters that it offered lower prices, promotions, new products and exclusivity in exchange for improved placement. Haleon said greater shelf visibility had supported its U.S. market share.

In a separate September 16 report, Reuters reported that Haleon had achieved growing U.S. sales of products addressing side effects associated with weight-loss drugs. The company said it was working with stores including CVS Pharmacy to place products in areas curated for consumers using GLP-1 medication as well as in regular aisles. Haleon said dual placement generated an average 24.00 percent sales lift per store in the first quarter.

Disclaimer...

en | GB00BMX86B70 | HALEON | boerse | 70194885 | bgmi